In this study, borneol-modified carbamazepine(1) nanoparticles were prepared by solvent diffusion method using PLGA as carrier material, and their tissue distribution in mice was investigated. First, the formulation was optimized by Box-Behnken design combined with response surface methodology with poloxamer 188 concentration, PLGA amount, the volume ratio of oil-to-water, and mass ratio of drug-to-lipid as the independent variables, and the entrapment efficiency and particle size as the dependent variables. The in vitro characterization results showed that the average particle size of the borneol-modified 1 nanoparticles prepared by the optimized formnlation was 90 – 100 nm, the entrapment efficiency and drug loading were about 72% and 6.7%. After tail intravenous administration of the self-made borneol-modified 1 nanoparticles to mice, the distribution behavior, especially the brain targeting of 1 in mice was investigated. The results showed that borneol-modified 1 nanoparticles could significantly extend the average residence time in mice, and borneol could promote the transport of 1 nanoparticles across the blood-brain barrier. The results indicated that the borneol-modified 1 nanoparticles had the potential to treat epilepsy.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |